🔗 Permalink

Inventor profile of:

Lynn Durham

City:

Geneva

Country:

Switzerland

Published Applications:

Last publication date:

2025-11-06

Top Assignees for applications by Lynn Durham

The entities that hold a legal rights for patent applications filed by inventor Durham Lynn:

Stalicla S.A. 9 Geneva, Switzerland
STALICLA SA 1 Geneve, Switzerland

Recent patent applications by Durham Lynn

Lynn Durham from Geneva, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-06

US20250339410A1

Human necessities

TREATMENT FOR AUTISM SPECTRUM DISORDER

#2 | 2025-09-25

US20250295641A1

Human necessities

TREATMENT FOR ASD

#3 | 2024-01-11

US20240011071A1

Chemistry; metallurgy

BIOMARKER ASSAY FOR USE IN MONITORING AUTISM

#4 | 2022-12-22

US20220406405A1

Physics

Computational Platform To Identify Therapeutic Treatments For Neurodevelopmental Conditions

#5 | 2022-01-06

US20220003753A1

Physics

METABOLIC PROFILING FOR THE DIAGNOSIS OF A SUBSET OF IDIOPATHIC AUTISM SPECTRUM DISORDER PATIENTS, ADS PHENOTYPE 1

#6 | 2021-06-10

US20210169993A1

Human necessities

TREATMENT OF A SUBTYPE OF ASD

#7 | 2021-05-27

US20210154177A1

Human necessities

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM

#8 | 2021-05-20

US20210145803A1

Human necessities

Pharmaceutical composition for the treatment of autism

#9 | 2020-10-15

US20200325519A1

Chemistry; metallurgy

BIOMARKER ASSAY FOR USE IN MONITORING AUTISM

#10 | 2019-05-09

US20190134230A1

Human necessities

Challenge test for diagnosing subtypes of ASD

#11 | 2019-05-09

US20190134229A1

Human necessities

Method of identifying ASD phenotype 1 patients

#12 | 2019-05-09

US20190134152A1

Human necessities

Treatment of a subtype of ASD

#13 | 2019-05-09

US20190134011A1

Human necessities

Pharmaceutical composition for the treatment of autism

InventorID:

2492230 ⎘